Systems Biology and Bioinformatics approach to Identify blood based signatures molecules and drug targets of patient with COVID-19

• DOI: 10.1016/j.imu.2021.100840
• Publication Date: 2021-12-30T07:43:17Z
• Authors: Md. Imran Hasan; Md Habibur Rahman; M. Babul Islam; Md Zahidul Islam; Md Arju Hossain; Mohammad Ali Moni
• Keywords: Biomarker signatures; 0303 health sciences; 03 medical and health sciences; Blood common gene; Computer applications to medicine. Medical informatics; Differentially expressed genes; R858-859.7; COVID-19; Gene ontology; PBMCs cell; Article; 3. Good health

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection results in the development of a highly contagious respiratory ailment known as new coronavirus disease (COVID-19). Despite the fact that the prevalence of COVID-19 continues to rise, it is still unclear how people become infected with SARS-CoV-2 and how patients with COVID-19 become so unwell. Detecting biomarkers for COVID-19 using peripheral blood mononuclear cells (PBMCs) may aid in drug development and treatment. This research aimed to find blood cell transcripts that represent levels of gene expression associated with COVID-19 progression. Through the development of a bioinformatics pipeline, two RNA-Seq transcriptomic datasets and one microarray dataset were studied and discovered 102 significant differentially expressed genes (DEGs) that were shared by three datasets derived from PBMCs. To identify the roles of these DEGs, we discovered disease-gene association networks and signaling pathways, as well as we performed gene ontology (GO) studies and identified hub protein. Identified significant gene ontology and molecular pathways improved our understanding of the pathophysiology of COVID-19, and our identified blood-based hub proteins TPX2, DLGAP5, NCAPG, CCNB1, KIF11, HJURP, AURKB, BUB1B, TTK, and TOP2A could be used for the development of therapeutic intervention. In COVID-19 subjects, we discovered effective putative connections between pathological processes in the transcripts blood cells, suggesting that blood cells could be used to diagnose and monitor the disease's initiation and progression as well as developing drug therapeutics.